2026 Summer Internship Program: Vaccine Business Unit Product Operations Assay Development Intern jobs in United States
info-icon
This job has closed.
company-logo

Takeda · 2 months ago

2026 Summer Internship Program: Vaccine Business Unit Product Operations Assay Development Intern

Takeda is a leading pharmaceutical company focused on vaccine development. The VBU Product Operations Assay Development Intern will plan and execute wet-lab experiments, analyze data, and present results to support the analytical lifecycle management of commercial vaccines.

BiotechnologyHealth CareManufacturingMedicalPharmaceutical
badNo H1Bnote

Responsibilities

Plan and execute wet-lab experiments
Analyze data
Interpret and present results and conclusions to the larger development team
Use findings to inform further development strategy and/or finalize analytical procedure operating parameters

Qualification

Analytical methodologiesWet-lab experimentsData analysisMolecular characterizationResearch laboratory experienceMicropipette usageSafety complianceTeam collaboration

Required

Must be pursuing a Bachelors Degree in biology, chemistry, biochemistry, or another relevant field
Basic experience in a research laboratory, including usage of micropipettes
Willingness to wear appropriate PPE to meet safety requirements while working in a BSL-2 environment
Demonstrated ability to work effectively as a collaborative team member
Must be authorized to work in the U.S. on a permanent basis without requiring sponsorship
Must be currently enrolled in a degree program graduating December 2026 or later
Able to work full time 40 hours a week during internship dates

Benefits

Paid sick time
Civic Duty paid time off
Participation at company volunteer events
Participation at company sponsored special events
Access to on-site fitness center (where available)
Commuter Benefit: To offset your work-commute expenses, Takeda provides U.S. employees with a fixed monthly subsidy to be used for either public transportation (transit) or parking.

Company

Takeda

twittertwittertwitter
company-logo
Takeda is a biopharmaceutical company that researches and develops pharmaceutical drugs.

Funding

Current Stage
Public Company
Total Funding
$2.46B
2025-06-27Post Ipo Debt· $2.4B
2016-09-01Grant· $19.8M
2016-05-08Grant· $38M

Leadership Team

leader-logo
Christophe Weber
President and CEO
linkedin
leader-logo
Schuyler Fairfield
Senior Vice President, Global Head of Supply Chain
linkedin
Company data provided by crunchbase